About the Event
Preverna’s A.I.-powered, protein targeting platform improves the efficacy of existing small molecule oncology treatments by making sure they are used on people most likely to respond favorably. This affords Preverna the opportunity to negotiate favorable agreements with large pharma companies.
Our fireside chat will cover how company advisor, author, and Harvard Business School professor, Deepak Malhotra is helping Preverna negotiate successful partnerships for its innovative platform.
Please join this fireside chat with Professor Malhotra and Ashkan Afshin, Co-Founder & CEO of Preverna to learn more about the company’s revolutionary approach to cancer drug development and how they’re working with others to improve cancer care.